peter md semaglutide reviews Tirzepatide appointment times could be 5 Dr. Peter Sinaiko, MD, Langhorne,

Medicare does not cover weight-management indications for weight alone as of April 2026, though some products carry cardiovascular-indication coverage

Desire an FDA-approved, well-tolerated non-surgical weight loss treatment Who Should Not Use GLP-1 Medications These medications are not appropriate for patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2)

These medicines include semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist rather than a pure GLP-1 agonist

The study was exempted from the requirement for approval by the ethics committee of Pusan National University Hospital (IRB no